China Shineway Pharmaceutical Group Limited (C1S) — Financial Flexibility Index
China Shineway Pharmaceutical Group Limited (C1S) has a Financial Flexibility Index of 0.08x as of June 2023. Free cash flow of €185.26 Million (operating CF €160.69 Million minus capex €24.57 Million) represents 0% of total liabilities (€2.26 Billion). Check strategic asset allocation of China Shineway Pharmaceutical Group Limi to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China Shineway Pharmaceutical Group Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. See working capital position of China Shineway Pharmaceutical Group Limi to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year free cash flow to debt coverage for China Shineway Pharmaceutical Group Limited. For the full company profile including market capitalisation, see China Shineway Pharmaceutical Group Limi (C1S) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €1.37 Billion | €1.17 Billion | €2.72 Billion | ▲ +17.7% |
| 2024 | 0.43x | €1.10 Billion | €963.13 Million | €2.57 Billion | ▲ +1.0% |
| 2023 | 0.42x | €1.08 Billion | €932.63 Million | €2.54 Billion | ▼ -36.7% |
| 2022 | 0.67x | €1.24 Billion | €1.11 Billion | €1.85 Billion | ▲ +9.5% |
| 2021 | 0.61x | €796.78 Million | €703.15 Million | €1.30 Billion | ▲ +23.2% |
| 2020 | 0.50x | €704.59 Million | €638.57 Million | €1.42 Billion | ▲ +47.3% |
| 2019 | 0.34x | €456.40 Million | €368.00 Million | €1.35 Billion | ▼ -50.7% |
| 2018 | 0.68x | €659.92 Million | €532.59 Million | €966.01 Million | ▼ -1.0% |
| 2017 | 0.69x | €582.47 Million | €490.65 Million | €844.16 Million | ▼ -31.1% |
| 2016 | 1.00x | €840.32 Million | €733.53 Million | €838.59 Million | ▲ +0.9% |
| 2015 | 0.99x | €851.26 Million | €744.71 Million | €857.13 Million | ▲ +14.8% |
| 2014 | 0.86x | €877.34 Million | €773.16 Million | €1.01 Billion | ▲ +44.8% |
| 2013 | 0.60x | €781.77 Million | €519.89 Million | €1.31 Billion | — |